JP Morgan initiated coverage on Blade Air Mobility with a new price target
$BLDE
Transportation Services
Consumer Discretionary
JP Morgan initiated coverage of Blade Air Mobility with a rating of Overweight and set a new price target of $16.00
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 2/26/2025 | $6.50 | Buy | Lake Street |
| 7/18/2023 | $13.00 | Buy | Ladenburg Thalmann |
| 7/17/2023 | $13.00 | Buy | Ladenburg Thalmann |
| 9/28/2021 | $14.00 | Outperform | Oppenheimer |
| 9/9/2021 | $16.00 | Overweight | JP Morgan |
| 9/2/2021 | $15.00 | Buy | Deutsche Bank |
| 9/1/2021 | $15.00 | Buy | Deutsche Bank |
| 8/26/2021 | $14.00 | Outperform | Credit Suisse |
4 - Strata Critical Medical, Inc. (0001779128) (Issuer)
4 - Strata Critical Medical, Inc. (0001779128) (Issuer)
4 - Strata Critical Medical, Inc. (0001779128) (Issuer)
NEW YORK, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (NASDAQ:SRTA, ", Strata", or the ", Company", )), formerly known as Blade Air Mobility, Inc. (NASDAQ:BLDE), will hold an Investor Day at the Nasdaq MarketSite in New York City on Monday, November 17th 2025. The event will begin at 2:00pm ET and will include presentations by members of the management team. Investors and analysts can register for the Investor Day on the events section of Strata's Investor Relations website that can be found here. A live video webcast and presentation materials will be available on the day of the event at ir.stratacrtical.com. About Strata Critical Medical Strata is a time-critical
Keystone is expected to generate approximately $65 million of revenue and approximately $13 million of Adjusted EBITDA(1) in the full-year 2025, with revenue expected to grow more than 50% in 2025 versus 2024Acquisition follows multi-year partnership between Strata and Keystone whereby Keystone has successfully recovered hundreds of organs on behalf of Strata customers$124 million acquisition represents an approximate 9x multiple of 2025 estimated Adjusted EBITDA(1); Keystone's go forward Free Cash Flow(1) conversion is expected to be approximately 80% NEW YORK, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (NASDAQ:SRTA, ", Strata", or the ", Company", )), formerly
NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (NASDAQ:SRTA, "Strata" or the "Company")), formerly known as Blade Air Mobility, Inc. (NASDAQ:BLDE) today announced that Will Heyburn, Co-Chief Executive Officer and Chief Financial Officer, will present at the 2025 Jefferies Industrials Conference on Thursday, Sept 4, 2025 at 11:30am ET. A webcast of the event will be available at the link here. A replay will be available shortly after the conclusion of the presentation on the investor relations section of the Company's website at https://ir.stratacritical.com/news-events. About Strata Critical Medical Strata Critical Medical provides time critical logistics solu
4 - Blade Air Mobility, Inc. (0001779128) (Issuer)
4 - Blade Air Mobility, Inc. (0001779128) (Issuer)
4 - Blade Air Mobility, Inc. (0001779128) (Issuer)
Lake Street initiated coverage of Blade Air Mobility with a rating of Buy and set a new price target of $6.50
Ladenburg Thalmann initiated coverage of Blade Air Mobility with a rating of Buy and set a new price target of $13.00
Ladenburg Thalmann initiated coverage of Blade Air Mobility with a rating of Buy and set a new price target of $13.00
8-K - Strata Critical Medical, Inc. (0001779128) (Filer)
8-K/A - Strata Critical Medical, Inc. (0001779128) (Filer)
SCHEDULE 13G - Blade Air Mobility, Inc. (0001779128) (Subject)
Medical revenue increased 17.6% year-over-year in Q2 2025 Net loss improved by $7.6 million versus the prior year to $(3.7) million in Q2 2025; Adjusted EBITDA improved by $2.2 million versus the prior year to $3.2 million in Q2 2025(1)Blade Passenger division to be sold to Joby Aviation for up to $125 million; Blade's Medical division will remain a standalone public company, rebrand as Strata Critical Medical ("Strata")Sale is expected to be Adjusted EBITDA and Free Cash Flow neutral on a go forward basis NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Blade Air Mobility, Inc. (NASDAQ:BLDE, ", Blade", or the ", Company", )), today announced financial results for the second quarter e
NEW YORK, July 24, 2025 (GLOBE NEWSWIRE) -- Blade Air Mobility, Inc. (NASDAQ:BLDE, "Blade" or the "Company")), will release financial results for the second quarter ended June 30, 2025 on Tuesday, August 5, 2025 before the market opens. The company will hold a conference call the same day at 8:00 am Eastern Time to discuss the results. The call will be hosted by Rob Wiesenthal, Blade's Chief Executive Officer, and Will Heyburn, Blade's Chief Financial Officer, and will include a question-and-answer session for call participants. To join the live call, please register here. Upon registration, a dial-in and unique PIN will be provided to join the call. An audio-only webcast of the call may
Net loss improved by $0.7 million versus the prior year to $(3.5) million in Q1 2025; Adjusted EBITDA improved by $2.3 million versus the prior year to $(1.2) million in Q1 2025(1)First Adjusted EBITDA profitable Q1 in the Passenger Segment since going public. Passenger Segment Adjusted EBITDA of $0.1 million in Q1 2025 represents a $2.7 million increase versus the prior year Q1 2025 revenue increased 5.4% versus the prior year to $54.3 million. Excluding Canada, which we exited in August 2024, revenue increased 10.9% versus the prior year period and Passenger Segment revenue increased 42.0% year-over-year(1)Achieved new monthly record for Medical trip volumes in April 2025Reaffirming guidan
NEW YORK, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Blade Air Mobility, Inc. (NASDAQ:BLDE, ", Blade", ))) an asset-light passenger air mobility and medical logistics company, today announced the appointment of Rémi Bouysset as CEO of Blade Europe. Blade Europe passengers can now enjoy helipad-side security clearance at Nice International Airport ("Nice Airport"), enabling helicopter fliers to connect directly to their commercial flights at their departing gates, bypassing the general security screening queues at the airport. Mr. Bouysset brings to Blade Europe a wealth of experience spanning 30 years in the travel, hospitality, and luxury sectors. The France-born executive led international c
NEW YORK, March 30, 2023 (GLOBE NEWSWIRE) -- The Board of Directors (the "Board") of Blade Air Mobility, Inc. (NASDAQ:BLDE, ", Blade", or the ", Company", ))), a technology-powered global air mobility platform, today announced the expansion of the Board from seven to nine members, and the appointment of two new directors, Andrew Lauck and John Borthwick. Mr. Lauck, a current Board observer for Blade, will officially join the Board as a director and will serve on the Audit Committee. Mr. Borthwick, a former Board member when Blade was private, will join the Nominating and Corporate Governance Committee. "We are pleased to welcome Andrew and John to our Board of Directors," said Eric Affeld
Appoints Two Industry Leaders to Establish European Presence Blade Air Mobility, Inc. (NASDAQ:BLDE, "Blade" or the "Company"))), a technology-powered global air mobility platform, today announced the creation of Blade Europe and the appointment of Sabrina Barbera as Executive Director of Blade Europe and Anne-Pascale Guedon as Executive Vice President, Business Development, Blade Europe. Blade Europe will be headquartered in Paris, France. Barbera has nearly 20 years of experience in aerospace and aviation and is currently a Vice-President at Airbus Helicopters overseeing their Simulation and Training department that trains over 8,000 pilots and technicians each year. Prior to this positi
SC 13G/A - Blade Air Mobility, Inc. (0001779128) (Subject)
SC 13G/A - Blade Air Mobility, Inc. (0001779128) (Subject)
SC 13G/A - Blade Air Mobility, Inc. (0001779128) (Subject)